Jacqualyn A Fouse's Net Worth
$26.6 Million
Who is Jacqualyn A Fouse?
Jacqualyn A Fouse has an estimated net worth of $26.6 Million. This is based on reported shares across multiple companies, which include BUNGE LTD, INCYTE CORP, AGIOS PHARMACEUTICALS, INC., DICKS SPORTING GOODS INC, PERRIGO Co plc, CELGENE CORP /DE/, and PERRIGO CO.
SEC CIK
Jacqualyn A Fouse's CIK is 0001405288
Past Insider Trading and Trends
2015 was Jacqualyn A Fouse's most active year for acquiring shares with 14 total transactions. Jacqualyn A Fouse's most active month to acquire stocks was the month of May. 2015 was Jacqualyn A Fouse's most active year for disposing of shares, totalling 9 transactions. Jacqualyn A Fouse's most active month to dispose stocks was the month of January. 2008 saw Jacqualyn A Fouse paying a total of $2,133,929.86 for 19,390 shares, this is the most they've acquired in one year. In 2016 Jacqualyn A Fouse cashed out on 38,643 shares for a total of $2,262,787.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BUNGE LTD No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 4
| -25.17% | -8.67K |
$54.59 | -$473,186.12 | 25.77K |
Jul 23
| |||
Form 4
| +0.22% | 74 |
$48.61 | $3,597.14 | 34.43K |
Jun 2
| |||
Form 4
| +0.17% | 58 |
$61.11 | $3,544.38 | 34.36K |
Mar 2 - Mar 3
| |||
Form 4
| +0.16% | 55 |
$65.02 | $3,576.10 | 34.3K |
Dec 2
| |||
Form 4
| +0.16% | 54 |
$65.11 | $3,515.67 | 34.25K |
Sep 2
| |||
Form 4
| -20.39% | -8.76K |
$66.74 | -$584,375.44 | 34.19K |
Jul 23
| |||
Form 4
| +0.22% | 95 |
$67.59 | $6,421.05 | 42.95K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
| +0.34% | 144 |
$44.45 | $6,400.80 | 42.85K |
Mar 2
| |||
Form 4
| +0.39% | 168 |
$37.92 | $6,370.56 | 42.71K |
Dec 2
| |||
Form 4
| +0.18% | 75 |
$84.78 | $6,358.13 | 42.54K |
Sep 3
| |||
Form 4
| -15.60% | -7.85K |
$98.30 | -$771,556.70 | 42.47K |
Jul 23
| |||
Form 4
| +0.14% | 70 |
$120.34 | $8,423.80 | 50.31K |
Jun 2
| |||
Form 4
| +0.15% | 77 |
$110.74 | $8,527.37 | 50.24K |
Feb 29
| |||
Form 4
| +0.15% | 75 |
$112.61 | $8,445.38 | 50.17K |
Nov 30
| |||
Form 4
| +0.19% | 93 |
$91.23 | $8,483.92 | 50.09K |
Aug 31
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
INCYTE CORP (INCY) Snapshot price: $60.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.25% | 2.83K |
—
|
—
| 16.81K |
Jun 12
| |||
Form 4
| +21.83% | 2.5K |
—
|
—
| 13.98K |
Jun 14
| |||
Form 4
| +2.25% | 252 |
$80.32 | $20,240.64 | 11.47K |
Scheduled
|
Dec 30
| ||
Form 4
| +2.66% | 291 |
$66.64 | $19,392.24 | 11.22K |
Scheduled
|
Sep 30
| ||
Form 4
| +2.58% | 275 |
$75.97 | $20,891.75 | 10.93K |
Scheduled
|
Jun 30
| ||
Form 4
| +25.19% | 2.14K |
—
|
—
| 10.65K |
Jun 15
| |||
Form 4
| +3.40% | 280 |
$79.42 | $22,237.60 | 8.51K |
Scheduled
|
Mar 31
| ||
Form 4
| +3.64% | 289 |
$73.40 | $21,212.60 | 8.23K |
Scheduled
|
Dec 31
| ||
Form 4
| +3.53% | 271 |
$68.78 | $18,639.38 | 7.94K |
Scheduled
|
Sep 30
| ||
Form 4
| +3.20% | 238 |
$84.13 | $20,022.94 | 7.67K |
Scheduled
|
Jun 30
| ||
Form 4
| +34.90% | 1.92K |
—
|
—
| 7.43K |
May 26
| |||
Form 4
| +4.77% | 251 |
$81.27 | $20,398.77 | 5.51K |
Scheduled
|
Mar 31
| ||
Form 4
| +4.72% | 237 |
$86.98 | $20,614.26 | 5.26K |
Scheduled
|
Dec 31
| ||
Form 4
| +4.56% | 219 |
$89.74 | $19,653.06 | 5.02K |
Scheduled
|
Sep 30
| ||
Form 4
| +4.39% | 202 |
$103.97 | $21,001.94 | 4.8K |
Scheduled
|
Jun 30
| ||
Form 4
| +38.63% | 1.28K |
—
|
—
| 4.6K |
May 26
| |||
Form 4
| +8.86% | 270 |
$73.23 | $19,772.10 | 3.32K |
Scheduled
|
Mar 31
| ||
Form 4
| +7.70% | 218 |
$87.32 | $19,035.76 | 3.05K |
Scheduled
|
Dec 31
| ||
Form 4
| +9.73% | 251 |
$74.23 | $18,631.73 | 2.83K |
Scheduled
|
Sep 30
| ||
Form 4
| +8.54% | 203 |
$84.96 | $17,246.88 | 2.58K |
Scheduled
|
Jun 28
| ||
Form 4
| +177.36% | 1.52K |
—
|
—
| 2.38K |
Apr 26
| |||
Form 4
| +20.37% | 145 |
$86.01 | $12,471.45 | 857 |
Scheduled
|
Mar 29
| ||
Form 4
| +37.98% | 196 |
$63.59 | $12,463.64 | 712 |
Scheduled
|
Dec 31
| ||
Form 4
| +53.57% | 180 |
$69.08 | $12,434.40 | 516 |
Scheduled
|
Sep 28
| ||
Form 4
| +124.00% | 186 |
$67.00 | $12,462.00 | 336 |
Scheduled
|
Jun 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
∞
| 150 |
$83.33 | $12,499.50 | 150 |
Scheduled
|
Mar 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $43.28
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +2.47% | 3.39K |
—
|
—
| 140.78K |
Jun 13
| |||
Form 4
| +6.30% | 8.14K |
$27.55 | -$214,642.05 | 137.4K |
Scheduled
|
Apr 8 - Apr 10
| ||
Form 4
| +11.35% | 13.18K |
$21.64 | -$232,024.08 | 129.25K |
Scheduled
|
Jan 20 - Jan 24
| ||
Form 4
| +8.52% | 9.11K |
$22.99 | -$192,909.09 | 116.08K |
Scheduled
|
Jan 5 - Jan 9
| ||
Form 4
| +14.06% | 13.18K |
$28.36 | -$303,962.48 | 106.97K |
Jun 28 - Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +13.56% | 11.2K |
$21.35 | -$101,006.85 | 93.78K |
Apr 8 - Apr 12
| |||
Form 4
| +10.26% | 7.68K |
$28.91 | -$105,463.68 | 82.58K |
Feb 14 - Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
| +13.15% | 8.71K |
$29.08 | -$106,839.92 | 74.9K |
Feb 18 - Feb 22
| |||
Form 4
| +13.41% | 7.83K |
$30.50 | -$106,902.50 | 66.19K |
Feb 14
| |||
Form 4
| +15.74% | 7.93K |
—
|
—
| 58.36K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| +20.87% | 8.71K |
$40.64 | -$149,270.72 | 50.43K |
Apr 13 - Apr 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +2,880.14% | 40.32K |
$31.00 | $1,249,982.00 | 41.72K |
Nov 13
| |||
Form 4
|
∞
| 1.4K |
—
|
—
| 1.4K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
DICKS SPORTING GOODS INC (DKS) Snapshot price: $208.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.80% | 9.52K |
—
|
—
| 55.29K |
Mar 22
| |||
Form 4
| +10.05% | 4.18K |
—
|
—
| 45.77K |
Apr 3
| |||
Form 4
| +12.84% | 4.73K |
—
|
—
| 41.59K |
Apr 3
| |||
Form 4
| +118.65% | 20K |
$27.13 | $542,600.00 | 36.86K |
Jun 20
| |||
Form 4
| +23.98% | 3.26K |
—
|
—
| 16.86K |
Apr 3
| |||
Form 4
| +20.75% | 2.34K |
—
|
—
| 13.6K |
Apr 3
| |||
Form 4
| +20.06% | 1.88K |
—
|
—
| 11.26K |
Apr 3
| |||
Form 4
| +26.93% | 1.99K |
—
|
—
| 9.38K |
Apr 3
| |||
Form 4
| +47.40% | 2.38K |
—
|
—
| 7.39K |
Apr 3
| |||
Form 4
| +82.29% | 2.26K |
—
|
—
| 5.01K |
Apr 3
| |||
Form 4
|
∞
| 2.75K |
—
|
—
| 2.75K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PERRIGO Co plc (PRGO) Snapshot price: $27.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +13.97% | 480 |
$95.70 | $45,936.00 | 3.92K |
May 4
| |||
Form 4
| +41.22% | 1K |
$146.90 | $147,340.70 | 3.44K |
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
∞
| 2.43K |
—
|
—
| 2.43K |
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |